Drug makers to vie for big pies over Plavix market

The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix (clopidogrel bisulfate) as the patent court has upheld that Korean makers' generic clopidogrel bisulfate does not infringes on Sanofi-Aventis's patent.

Chong Kun Dang and other drug makers are in great dismay over the court decision.

According to pharmaceutical sources, is likely not to get ...